SE7713233L - ALFA-PROTECTED OXIIMINO-BETA-OXO-GAMMA-HALOGENOSMORIC ACID DERIVATIVES FOR USE AS AN INTERMEDIATE PRODUCT FOR THE PREPARATION OF PHARMACEUTICALLY APPLICABLE CEFEM COMPOUNDS - Google Patents

ALFA-PROTECTED OXIIMINO-BETA-OXO-GAMMA-HALOGENOSMORIC ACID DERIVATIVES FOR USE AS AN INTERMEDIATE PRODUCT FOR THE PREPARATION OF PHARMACEUTICALLY APPLICABLE CEFEM COMPOUNDS

Info

Publication number
SE7713233L
SE7713233L SE7713233A SE7713233A SE7713233L SE 7713233 L SE7713233 L SE 7713233L SE 7713233 A SE7713233 A SE 7713233A SE 7713233 A SE7713233 A SE 7713233A SE 7713233 L SE7713233 L SE 7713233L
Authority
SE
Sweden
Prior art keywords
protected
beta
preparation
halogenosmoric
oxiimino
Prior art date
Application number
SE7713233A
Other languages
Swedish (sv)
Other versions
SE444809B (en
Inventor
M Ochiai
O Aki
A Morimoto
T Okada
K Kawakita
Y Matsushita
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE7713233L publication Critical patent/SE7713233L/en
Priority to JP1336578A priority Critical patent/JPS53121400A/en
Publication of SE444809B publication Critical patent/SE444809B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

NEW MATERIAL:A compound of formula I [X is halogen: Y and Z incorporate to form a group, =NR<5> (R<5> is protected hydroxyl)], its salt or ester. EXAMPLE:Ethyl alpha-ethoxyimino-2-aminothiazol-4-ylacetate hydrobromide. USE:A synthetic intermediate of antibacterials. PREPARATION:The customary halogenation of a compound of formula II such as a beta-ketobutyric acid bearing a protected oxyimino group in the alpha-position gives the compound of formula I . In the compound of formula I , methyl, phenyl or acetyl is cited as a protecting group for the hydroxyl and methyl, tolyl or benzyl for the carboxyl. The protected oxyimino group has syn- and anti-forms theoretically.
SE7713233A 1975-06-09 1977-11-23 ALFA-PROTECTED OXIIMINO-BETA-OXO-GAMMA-HALOGENSORIC ACID DERIVATIVES FOR USE AS INTERMEDIATE FOR THE PREPARATION OF PHARMACEUTICAL USEFUL CEFEM SOCIETIES SE444809B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1336578A JPS53121400A (en) 1977-02-07 1978-02-07 Method of supplying fuel with aeroplane and device for the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24611/75A GB1536281A (en) 1975-06-09 1975-06-09 Cephem compounds

Publications (2)

Publication Number Publication Date
SE7713233L true SE7713233L (en) 1977-11-23
SE444809B SE444809B (en) 1986-05-12

Family

ID=10214399

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7713233A SE444809B (en) 1975-06-09 1977-11-23 ALFA-PROTECTED OXIIMINO-BETA-OXO-GAMMA-HALOGENSORIC ACID DERIVATIVES FOR USE AS INTERMEDIATE FOR THE PREPARATION OF PHARMACEUTICAL USEFUL CEFEM SOCIETIES

Country Status (7)

Country Link
JP (5) JPS5822039B2 (en)
AT (2) AT344894B (en)
GB (1) GB1536281A (en)
HK (1) HK2282A (en)
HU (1) HU172304B (en)
MY (1) MY8200219A (en)
SE (1) SE444809B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154939C (en) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd METHOD OF ANALOGUE FOR THE PREPARATION OF THIAZOLYLACETAMIDO-CEPHEM COMPOUNDS OR PHARMACEUTICAL ACCEPTABLE SALTS OR ESTERS THEREOF
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds
FR2346014A1 (en) * 1976-01-23 1977-10-28 Roussel Uclaf Amino-thiazolyl-hydroxyimino-acetamido-cephalosporanic acids - with antibacterial activity
SE440655B (en) * 1976-01-23 1985-08-12 Roussel Uclaf SET TO MAKE NEW OXIME DERIVATIVES OF 7-AMINO-THIAZOLYL-ACETAMIDO-CEPHALOSPORANIC ACID
GB1576625A (en) * 1976-04-12 1980-10-08 Fujisawa Pharmaceutical Co Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof
FI771866A (en) * 1976-06-28 1977-12-29 Fujisawa Pharmaceutical Co
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
AU520269B2 (en) * 1977-03-14 1982-01-21 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
JPS5444695A (en) * 1977-09-13 1979-04-09 Fujisawa Pharmaceut Co Ltd 3,7-disubstituted-3-cephem-4-carboxylic acid and its salt and their preparation
US4370326A (en) * 1977-09-13 1983-01-25 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and composition
FR2410655A1 (en) * 1977-12-05 1979-06-29 Roussel Uclaf NEW OXIMES DERIVED FROM 3-SUBSTITUTE 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC, THEIR METHOD OF PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
DE2758001A1 (en) * 1977-12-24 1979-07-12 Hoechst Ag CEPHALOSPORINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION
FR2387235A1 (en) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co PROCESS FOR THE PREPARATION OF COMPOUNDS OF 3,7-DISUBSTITUE-3-CEPHEM-4-CARBOXYLIC ACID AND NEW PRODUCTS THUS OBTAINED, HAVING A STRONG ANTIBACTERIAL ACTIVITY
JPS54106495A (en) * 1978-02-09 1979-08-21 Dai Ichi Seiyaku Co Ltd Cephem derivative
JPS54128594A (en) * 1978-03-27 1979-10-05 Fujisawa Pharmaceut Co Ltd 3,7-disubstituted-3-cephem-4-carboxylic acid derivative
FR2432521A1 (en) * 1978-03-31 1980-02-29 Roussel Uclaf NOVEL O-SUBSTITUTED OXIMES DERIVED FROM 7-AMINO THIAZOLYL ACETAMIDO CEPHALOSPORANIC ACID, THEIR PREPARATION PROCESS AND THEIR USE AS MEDICAMENTS
DE2818263A1 (en) * 1978-04-26 1979-11-08 Bayer Ag BETA LACTAMANTIBIOTICS
US4703046A (en) * 1978-09-08 1987-10-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
BE878637A (en) * 1978-09-11 1980-03-06 Fujisawa Pharmaceutical Co PROCESS FOR THE PREPARATION OF 3,7-DISUBSTITUTED 3-CEPHEM-4-CARBOXYLIC ACID COMPOUNDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, NOVEL PRODUCTS THUS OBTAINED AND THEIR USE FOR THEIR ANTIMICROBIAL ACTIVITIES
JPS5543089A (en) * 1978-09-12 1980-03-26 Fujisawa Pharmaceut Co Ltd Preparation of 3-cephem compound
JPS5594354A (en) * 1979-01-12 1980-07-17 Fujisawa Pharmaceut Co Ltd Syn-isomer of 2-substituted imino-3-oxo-4-halobutyric acid, its salt, and their preparation
US4409215A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
JPS56125392A (en) * 1980-03-06 1981-10-01 Fujisawa Pharmaceut Co Ltd Cepham and cephem compound and preparation thereof
JPS57154175A (en) * 1981-03-16 1982-09-22 Mitsui Toatsu Chem Inc 2-thiazoleamine derivative, its preparation, and drug composition comprising it
US4457929A (en) * 1982-03-29 1984-07-03 Bristol-Myers Company 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives
ATE30724T1 (en) 1982-06-28 1987-11-15 Bristol Myers Co CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS6150973A (en) * 1983-11-16 1986-03-13 Fujisawa Pharmaceut Co Ltd Substituted iminoacetic acid derivative and salt and preparation thereof
IT1180207B (en) * 1984-07-30 1987-09-23 Istituto Biochimico Italiano PROCEDURE FOR THE PREPARATION, WITH HIGH YIELD AND PURITY, OF BETA-LACTAMIC ANTIBIOTICS
JPS60155167A (en) * 1984-07-31 1985-08-15 Fujisawa Pharmaceut Co Ltd Substituted iminoacetic acid derivative and its salt
JPS61121746U (en) * 1985-01-16 1986-07-31
EP0210815A3 (en) * 1985-07-25 1988-04-20 Beecham Group Plc 6-beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use
GB8519606D0 (en) * 1985-08-05 1985-09-11 Fujisawa Pharmaceutical Co 3 7-d substituted-3-cephem compounds
EP0373216A4 (en) * 1987-02-02 1992-08-12 Teijin Limited Cephalosporin compounds or their salts, process for their preparation, and parmaceutical compositions
AU1228988A (en) * 1987-02-03 1988-08-24 Teijin Limited Cephalosporin compounds or their salts, process for their preparation, and pharmaceutical compositions
JPH02281051A (en) * 1989-04-21 1990-11-16 Toyo Tire & Rubber Co Ltd Tread rubber composition for tire
JPH09110877A (en) 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk Cephem compound, its production and antibacterial agent containing the compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds

Also Published As

Publication number Publication date
ATA967775A (en) 1977-12-15
JPS61143388A (en) 1986-07-01
JPS6155905B2 (en) 1986-11-29
JPS5756485A (en) 1982-04-05
SE444809B (en) 1986-05-12
JPS51149296A (en) 1976-12-22
HK2282A (en) 1982-01-22
AT344894B (en) 1978-08-10
ATA517177A (en) 1978-05-15
JPS5858353B2 (en) 1983-12-24
JPS5989686A (en) 1984-05-23
HU172304B (en) 1978-07-28
AT347587B (en) 1979-01-10
JPH0346474B2 (en) 1991-07-16
JPS5822039B2 (en) 1983-05-06
JPS58185553A (en) 1983-10-29
GB1536281A (en) 1978-12-20
MY8200219A (en) 1982-12-31

Similar Documents

Publication Publication Date Title
SE7713233L (en) ALFA-PROTECTED OXIIMINO-BETA-OXO-GAMMA-HALOGENOSMORIC ACID DERIVATIVES FOR USE AS AN INTERMEDIATE PRODUCT FOR THE PREPARATION OF PHARMACEUTICALLY APPLICABLE CEFEM COMPOUNDS
ES483767A1 (en) Alpha-(N-arylsulfonyl-L-argininamides, processes for their preparation and pharmaceutical compositions containing these substances.
IE37767L (en) DERIVATIVES OF 7ß-AMINO-CEPHEM-3-OL-4-CARBOXYLIC ACIDS
JPS5283432A (en) Preparation and applications of 3-(2-aryl-2-propyl) urea derivatives
IE38979L (en) Tetrazolyl - quinoxalinecarboxamide derivatives
IE44069L (en) Noroxymorphones
NO142815C (en) ACETIDIN DERIVATIVES USED AS THE OUTSTANDING MATERIAL FOR THE PREPARATION OF CEPHALOSPORANIC ACID DERIVATIVES
ES8102109A1 (en) Aminothiazole oxime derivatives
SE7607300L (en) THIAXANTENE ASSOCIATIONS AND PROCEDURES FOR THE PREPARATION OF THEM
JPS5225740A (en) Preparation of o-acyl-amidinophenols or acid addition salts thereof
JPS5289695A (en) Novel 7alpha-methoxycephalosporins and preparation thereof
JPS5283722A (en) Dipeptide derivatives
JPS5697268A (en) Lower alkanoic acid derivative, salt and preparation thereof and preventing agent and remedy for diabetic complication containing the same as active constituent
JPS52100473A (en) Novel azimidebenzamide derivative and its production
JPS5540645A (en) Benzopyrone derivative
CA1034491A (en) Inhibiting discoloration of aqueous compositions containing hexamethylenetetramine 1,3-dichloropropene salts
JPS527946A (en) Preparation of indanylpropionic acid derivatives
JPS5384987A (en) Cephalosporin-analogous antibiotics
JPS5219669A (en) Preparation of tetrazole derivatives and acid addition salts thereof
JPS5227757A (en) Preparation of 6-aminomethylnaphthalene derivatives
JPS5251360A (en) Preparation of hydrofluorene dicarboxylic acid derivatives
JPS5283459A (en) Preparation of gamma-lactone derivative
JPS5259184A (en) Preparation of cephalosporin derivatives
AU494262B2 (en) Formulation of 2 methyl 4 chlorophenoxyacetic acid as its dimethylamine salt
JPS5283529A (en) Cyclohexanone derivatives

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7713233-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7713233-0

Format of ref document f/p: F